Diagnostic Accuracy of Procalcitonin upon Emergency Department Admission during SARS-CoV-2 Pandemic.
par Malinverni, Stefano
;Lazzaroni, Silvia;Nuňez, Maïa;Preseau, Thierry
;Cotton, Frédéric
;Martiny, Delphine
;Bouazza, Fatima-Zohra;Collot, Vincent
;Konopnicki, Deborah
;Alard, Stephane;Bartiaux, Magali ![](/vufind/images/ULB/publications_list.png)
Référence Antibiotics, 11, 9
Publication Publié, 2022-08
![](/vufind/images/ULB/publications_list.png)
![](/vufind/images/ULB/publications_list.png)
![](/vufind/images/ULB/publications_list.png)
![](/vufind/images/ULB/publications_list.png)
![](/vufind/images/ULB/publications_list.png)
![](/vufind/images/ULB/publications_list.png)
![](/vufind/images/ULB/publications_list.png)
Référence Antibiotics, 11, 9
Publication Publié, 2022-08
Article révisé par les pairs
Résumé : | Procalcitonin is a marker for bacterial diseases and has been used to guide antibiotic prescription. Procalcitonin accuracy, measured at admission, in patients with community-acquired pneumonia (CAP), is unknown in the current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. |